Innoviva, Inc.
INVA
$22.41
$0.090.40%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 103.91% | 47.61% | 0.68% | 61.52% | 48.85% |
| Total Other Revenue | -12.19% | 4.98% | 0.22% | -1.04% | -5.51% |
| Total Revenue | 24.84% | 20.44% | 0.39% | 14.37% | 6.95% |
| Cost of Revenue | 298.80% | 205.04% | 25.00% | 108.28% | -76.13% |
| Gross Profit | -5.20% | -7.33% | -1.90% | 9.08% | 72.97% |
| SG&A Expenses | 2.27% | 4.39% | -4.79% | -9.58% | 19.17% |
| Depreciation & Amortization | 1.94% | 1.64% | 1.66% | 0.54% | 0.02% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 59.52% | 56.78% | 13.98% | 4.70% | 16.41% |
| Operating Income | -11.45% | -15.45% | -10.85% | 27.64% | -1.43% |
| Income Before Tax | 689.81% | 1,328.19% | 284.83% | -185.52% | -59.65% |
| Income Tax Expenses | 608.00% | 40.33% | 293.95% | -6.95% | 1,421.82% |
| Earnings from Continuing Operations | 707.36% | 7,312.04% | 283.62% | -227.52% | -66.96% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 707.36% | 7,312.04% | 283.62% | -227.52% | -66.96% |
| EBIT | -11.45% | -15.45% | -10.85% | 27.64% | -1.43% |
| EBITDA | -9.75% | -13.27% | -9.51% | 23.09% | -1.25% |
| EPS Basic | 575.92% | 6,610.82% | 282.64% | -228.48% | -66.38% |
| Normalized Basic EPS | -23.65% | -19.24% | -6.62% | 36.20% | 7.19% |
| EPS Diluted | 594.28% | 5,474.74% | 239.30% | -260.80% | -63.25% |
| Normalized Diluted EPS | -9.96% | -33.95% | -30.49% | 82.26% | 6.35% |
| Average Basic Shares Outstanding | 19.43% | 10.37% | 0.54% | -0.75% | -1.70% |
| Average Diluted Shares Outstanding | 1.26% | 34.97% | 35.07% | -25.82% | -0.94% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |